University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Dental Block for Pain Relief in ED Dental Pain Patients

Recruiting

Conditions: Dental Pain

First Posted Date: 2022-04-28

Last Posted Date: 2023-06-28

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 195

Registration Number: NCT05351099

Locations: 🇺🇸
Community Regional Trauma and Burn Center, Fresno, California, United States

Lemborexant Shift Work Treatment Study

Phase 4

Recruiting

Conditions: Shift-Work Related Sleep Disturbance

Interventions: Drug: Placebo
Drug: Lemborexant

First Posted Date: 2022-04-25

Last Posted Date: 2024-06-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 45

Registration Number: NCT05344443

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Effect of Rapid Rollover on Pneumothorax After CT-Guided Lung Biopsy

Not Applicable

Recruiting

Conditions: Lung Cancer
Pneumothorax

Interventions: Procedure: Rapid Rollover

First Posted Date: 2022-04-25

Last Posted Date: 2023-11-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 126

Registration Number: NCT05342675

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, United States

Urine Tenofovir Point-of-care Test to Identify Patients in Need of ART Adherence Support (UTRA Study)

Not Applicable

Active, not recruiting

Conditions: Risk Reduction

Interventions: Device: UTRA
Behavioral: UTRA feedback

First Posted Date: 2022-04-19

Last Posted Date: 2024-07-26

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 200

Registration Number: NCT05333679

Locations: 🇿🇦
Desmond Tutu Health Foundation, University of Cape Town, Cape Town, Western Cape, South Africa

Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Other: STAND-T platform
Other: Survey Administration
Other: Text Messages

First Posted Date: 2022-04-12

Last Posted Date: 2024-06-10

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 47

Registration Number: NCT05324098

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Zuckerberg San Francisco General Hospital, San Francisco, California, United States

Comparing the Effects of Psilocin and Psilocybin in Healthy Adults

Phase 1

Recruiting

Conditions: Healthy

Interventions: Drug: Psilocin
Drug: Psilocybin
Drug: Sublingual Psilocin

First Posted Date: 2022-04-08

Last Posted Date: 2023-12-12

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT05317689

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Validation of the Diabetes Deep Neural Network Score for Diabetes Mellitus Screening

Not Applicable

Active, not recruiting

Conditions: Diabetes

Interventions: Device: Application Validation

First Posted Date: 2022-03-31

Last Posted Date: 2024-01-29

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 6006

Registration Number: NCT05303051

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Peri-operative Oral Pain Control Following Buccal Graft Urethroplasty

Phase 3

Recruiting

Conditions: Urethral Stricture, Male

Interventions: Drug: Standard Buccal Harvest
Drug: Basic buccal procedure + Long acting local
Drug: Basic buccal procedure + Buccal block

First Posted Date: 2022-03-29

Last Posted Date: 2024-05-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT05300685

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸
MedStar Urology, Washington, District of Columbia, United States

Ocular Rosacea Biome Study

Phase 4

Recruiting

Conditions: Ocular Rosacea
Antimicrobial Resistance

Interventions: Drug: Placebo
Drug: Doxycycline 40 MG ( 20mg twice daily)
Drug: Doxycycline 200 MG ( 100 mg twice daily)

First Posted Date: 2022-03-25

Last Posted Date: 2024-02-26

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 50

Registration Number: NCT05296837

Locations: 🇺🇸
University of California, San Farncisco, San Francisco, California, United States

Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures

Phase 4

Completed

Conditions: Eyelid Abscess
Eyelid Papilloma
Eyelid Boil
Eyelid Tumor
Eyelid Bump
Eyelid Deformity
Anesthesia, Local
Ophthalmology

Interventions: Drug: 0.9% Bacteriostatic Local Anesthetic Injection
Procedure: Eyelid Lesion Removal

First Posted Date: 2022-03-24

Last Posted Date: 2023-12-29

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 95

Registration Number: NCT05294640

Locations: 🇺🇸
University of California at San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy